In non-alcoholic steatohepatitis (NASH), LECT2 promotes of TNF-α and Monocyte Chemoattractant Protein-1 (MCP-1) expression, increasing macrophage infiltration, and facilitating liver inflammation (27–29). Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.